Obesity Treatment Market

Posted by ahila on April 26th, 2018

Global Obesity Treatment Market :Obesity is the medical condition occurs due to the excessive or abnormal accumulation of fat inside the body. Obesity is measured with respect to Basal Metabolic Index (BMI). According to world health organization, more than 30 BMI is considered as the obese. Obesity may lead to osteoarthritis, cardiovascular diseases, diabetes, and various types of cancer. The risk factors for obesity include lack of physical exercise, excessive food intake, endocrine disorders, genetic inheritance, and due to some medications.  obesity treatment reduces the body mass either by an increase in calorie consumption or by the decrease in craving.

 Increase in the prevalence of obese population around the globe, increase in R&D activities for the innovation of new treatment, change in lifestyle such as food habits, and genetic inheritance is the major factors anticipated fuel the obesity treatment market over the forecast period. Moreover, increase in awareness about obesity treatment, huge pipeline products available for the obesity treatment, and government initiations for increasing awareness about chronic nature of obesity are propelling the obesity treatment market. However, high cost for R&D activities, alternative treatment for the obesity, adverse effects associated with the treatment, and stringent regulatory guidelines might hinder the growth of Obesity Treatment Market

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-obesity-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

Global obesity treatment market segmented on the basis of drug type, mechanism of action, distribution mode, route of administration, and distribution channel

Based on the medicine type, obesity treatment market segmented into the following:

• Centrally acting obesity medicines
• Peripherally acting obesity medicines

Based on the mechanism of action, obesity treatment market segmented into the following:

• Serotonin-Norepinephrine-Dopamine reuptake inhibitors (SNDRIs)
• Serotonin reuptake inhibitors
• Sympathomimetic-GABA receptor agonists
• Sympathomimetics
• Others

Based on the distribution mode, obesity treatment market segmented into the following:

• Over-the-counter medicines
• Prescription medicines

Based on the route of administration, obesity treatment market segmented into the following:

• Oral
• Injectables

Based on the distribution channel, obesity treatment market segmented into the following:

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-obesity-treatment-market/#ulp-c654SbFYO64MsOhu